Maher A.
Leading Global Medical Affairs for Innovative Autoimmune Therapies
- Role
- Executive Director, Global Medical Affairs, Ianalumab and Rapcabtagene Autoleucel Programs at Novartis
- Location
- East Hanover, NJ, US
- LinkedIn followers
- 500 followers
About Maher A.
With over a decade of experience in global medical affairs, I currently lead strategies for early and late-stage immunology programs as Executive Director at Novartis. My work focuses on driving integrated evidence plans, fostering collaborations, and enhancing access to innovative therapies, including CAR-Ts, monoclonal antibodies, and biologics. Committed to advancing healthcare solutions, I build and support high-performing teams to address the needs of patients and families affected by autoimmune diseases. My expertise spans monoclonal antibodies, biologics, and clinical trials, enabling impactful contributions to global medical initiatives.
Experience
Executive Director, Global Medical Affairs, Ianalumab and Rapcabtagene Autoleucel Programs
Dec 2023 — Present · NJ, US
Drive global medical affairs strategies, in early and late-stage Immunology programs; Build impactful integrated evidence plans; Foster partnerships and collaborations aiming to maximize access to innovative new therapies (such as CAR-Ts, monoclonal antibodies, biologic therapies); Develop and support high performing research and medical affairs teams to bring innovative treatments and healthcare solutions to patients and families living with autoimmune diseases.
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.